Human Recombinant IL-37

Interleukin 37

Human Recombinant IL-37

Interleukin 37

From: 765 USD
Catalog #
(Select a product)
Interleukin 37
Add to Wish List

Overview

Use Interleukin 37 (IL-37) to inhibit the expression of inflammatory cytokines, such as IL-6, MIP-1α, MIP-1β, and TNF-α, in a MAPK-dependent manner (Qi et al.). A secreted protein belonging to the interleukin-1 cytokine family, IL-37 acts as an anti-inflammatory alarmin, with predominant expression in monocytes, and constitutive secretion by myeloid dendritic cells (Rudloff et al.). IL-37 has been shown to limit inflammation in human blood M1 macrophages by binding to extracellular surface receptors, requiring IL-1R8 as a coreceptor (Li et al.). It also has protective effects against obesity-induced inflammation and insulin resistance, reducing adipogenesis and activating AMPK signaling both in vitro and in vivo (Ballak et al.). In humans, the IL-37 gene undergoes alternative splicing, resulting in multiple isoforms of the protein (Boraschi et al.). For consistency and reproducibility across your applications, Interleukin 37 from STEMCELL comes lyophilized with ≥ 93% purity.
Subtype
Cytokines
Alternative Names
FIL1, FIL1(ZETA), FIL1Z, IL1F7, IL-1F7, IL-1H, IL1H4, IL-1H4, IL1RP1, IL-1RP1, IL37
Species
Human
Area of Interest
Metabolism
Purity
≥ 93%

Data Figures

Human Recombinant IL-37 was resolved with SDS-PAGE under reducing (+) conditions and visualized by Coomassie Blue staining. Human Recombinant IL-37 has a predicted molecular mass of 18.7 kDa.

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
100-1320
Lot #
All
Language
English
Document Type
Safety Data Sheet
Catalog #
100-1320
Lot #
All
Language
English